Quick Answer
IDEAYA Biosciences, Inc. reported Stockholders Equity of $1.02 billion for the year ending 2025.
- IDEAYA Biosciences, Inc. showed a decrease of -3.4% in Stockholders Equity from 2024 to 2025.
- This data is from IDEAYA Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$21.31 million | Q2 2018: -$28.05 million | Q3 2018: -$40.74 million | Q1 2019: -$58.06 million | Q2 2019: $120.61 million | Q3 2019: $110.41 million | Q1 2020: $89.10 million | Q2 2020: $172.06 million | Q3 2020: $195.43 million | Q1 2021: $233.13 million | Q2 2021: $240.26 million | Q3 2021: $317.63 million | Q1 2022: $288.67 million | Q2 2022: $269.32 million | Q3 2022: $368.77 million | Q1 2023: $333.81 million | Q2 2023: $501.61 million | Q3 2023: $508.05 million | Q1 2024: $935.31 million | Q2 2024: $931.66 million | Q3 2024: $1.18 billion | Q1 2025: $1.02 billion | Q2 2025: $959.65 million | Q3 2025: $1.09 billion.
- Over the full 10 years of available data (2016 to 2025), IDEAYA Biosciences, Inc.'s Stockholders Equity has grown by 24,856.4%.
- Historical annual values: Fiscal year 2025: $1.02 billion | Fiscal year 2024: $1.06 billion | Fiscal year 2023: $621.09 million | Fiscal year 2022: $349.46 million | Fiscal year 2021: $301.51 million | Fiscal year 2020: $198.27 million | Fiscal year 2019: $100.40 million | Fiscal year 2018: -$48.95 million | Fiscal year 2017: -$15.74 million | Fiscal year 2016: -$4.13 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: